Af­ter years of part­ner­ships, AI biotech Ex­sci­en­tia lands first ma­jor fi­nanc­ing round at $60M

Af­ter years rack­ing up part­ner­ships with biotechs and Big Phar­ma, the AI drug de­vel­op­er Ex­sci­en­tia has land­ed its first large fi­nanc­ing round.

The UK-based com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER